Ali Tinazli's guest appearances

Ali Tinazli

DeviceAlliance: MedTech Radio

Domus Search - The European BioTech, Pharma & MedTech C-Suite Leadership Podcast

IEEE Digital Privacy

Scott Anderson

Jeff Blanton

David Powell

Travis Smith

Patrick Johnson

Warren Foust

William Curtis

Jon Speer

Stan Rowe

Annette Walker

Ben Bobo

Jill Bigelow

Dave Saunders

Dave Ferrera

Andrew Lyon

OwlTail

In this episode of the IEEE Digital Privacy Podcast Series, Dr. Ali Tinazli, an active member of the IEEE Engineering in Medicine &amp; Biology Society, shares his insights on digital privacy and its impact on healthcare, both for companies and individuals.

Episode 5: A Conversation with Dr. Ali Tinazli, CEO, lifespin

On this show, I'm delighted to sit down in conversation with Lifespin CEO Dr Ali Tinazli based in Germany, to record a video podcastfor the Domus Search Leadership Podcast.  Domus Search is committed to sharing leadership insight to our network. The podcast offers a glimpse into the world of industry leaders through interactive conversations with CEO's, C-Suite Executives and Executive Leadership Teams across European BioPharma and MedTech sectors.  About my guest.  Dr Ali Tinazli completed his MSc in Biochemistry, Biophysics and Molecular Biology and went on to achieve his PhD in Nanotechnology from Goethe University, Germany. He went on to complete Executive Education with Massachusetts Institute of Technology, MIT Professional Education and Univesity of California, Berkeley, Haas School of Business.  Since completing his PhD, Ali has gone on to take leadership roles in many household names such as Sony and HP, where he led the global strategy governing the company’s initiatives in Healthcare and Life Sciences, with a focus on Point of Care and Digital Health  Ali sits on the Board of Softhread, a a blockchain and AI-enabled platform to build enterprise solutions and Fluxergy, a Point of Care Health Diagnostic Solutions based in California. He is also a member of the Forbes Technology Council  As CEO of lLifespin, amongst many other responsibilities, Ali is charged with the leadership and growth of Lifespin into new regions, developing strategic partnerships and putting Lifespin on the map. His global expertise and subject matter expertise positions Ali  at the intersection of consumer technologies and healthcare, commercialising technology in Life Sciences and in vitro diagnostics.   About Lifespin.  The Lifespin platform combines biology, deep data, artificial intelligence and cloud technologies to enable digital metabolic insights for Precision diagnostics, Personalised Disease management, Precision Drug Monitoring for Pharma, Research and much more.  Lifespin is building a proprietary database, already consisting of more than 150k individual human metabolic profiles, to create a digital atlas of human health that provides deeper clinical insights based on metabolic information.  The first commercial product in the regulated space will be software algorithms for health testing this year as a laboratory-developed test for clinical evaluation of Multiple Sclerosis followed by a test for Parkinson’s Disease diagnosis in 2023. The clinical findings to date using lifespin’s technology platform in a research-use-only context are highly promising.  Connect with Dr Ali. https://lifespin.health https://www.linkedin.com/in/dralitinazli/ Keep in touch with Lifespin &amp; Dr Ali at industry events https://lifespin.health/newsroom/

On this show, I'm delighted to sit down in conversation with <a href="https://www.linkedin.com/company/lifespin/" rel="nofollow" target="_blank">L</a>ifespin CEO Dr Ali Tinazli based in Germany, to record a video podcastfor the Domus Search Leadership Podcast. Domus Search is committed to sharing leadership insight to our network. The <a href="https://www.linkedin.com/company/domussearchpodcast/" rel="nofollow" target="_blank">p</a>odcast offers a glimpse into the world of industry leaders through interactive conversations with CEO's, C-Suite Executives and Executive Leadership Teams across European BioPharma and MedTech sectors. About my guest. Dr Ali Tinazli completed his MSc in Biochemistry, Biophysics and Molecular Biology and went on to achieve his PhD in Nanotechnology from Goethe University, Germany. He went on to complete Executive Education with Massachusetts Institute of Technology, MIT Professional Education and Univesity of California, Berkeley, Haas School of Business. Since completing his PhD, Ali has gone on to take leadership roles in many household names such as Sony and HP, where he led the global strategy governing the company’s initiatives in Healthcare and Life Sciences, with a focus on Point of Care and Digital Health Ali sits on the Board of <a href="https://www.linkedin.com/company/softhreadtechnology/" rel="nofollow" target="_blank">S</a>ofthread, a a blockchain and AI-enabled platform to build enterprise solutions and <a href="https://www.linkedin.com/company/fluxergy/" rel="nofollow" target="_blank">F</a>luxergy, a Point of Care Health Diagnostic Solutions based in California. He is also a member of the Forbes Technology Council As CEO of <a href="https://www.linkedin.com/company/lifespin/" rel="nofollow" target="_blank">lL</a>ifespin, amongst many other responsibilities, Ali is charged with the leadership and growth of Lifespin into new regions, developing strategic partnerships and putting <a href="https://www.linkedin.com/company/lifespin/" rel="nofollow" target="_blank">L</a>ifespin on the map. His global expertise and subject matter expertise positions Ali  at the intersection of consumer technologies and healthcare, commercialising technology in Life Sciences and in vitro diagnostics.  About Lifespin. The Lifespin platform combines biology, deep data, artificial intelligence and cloud technologies to enable digital metabolic insights for Precision diagnostics, Personalised Disease management, Precision Drug Monitoring for Pharma, Research and much more. Lifespin is building a proprietary database, already consisting of more than 150k individual human metabolic profiles, to create a digital atlas of human health that provides deeper clinical insights based on metabolic information. The first commercial product in the regulated space will be software algorithms for health testing this year as a laboratory-developed test for clinical evaluation of Multiple Sclerosis followed by a test for Parkinson’s Disease diagnosis in 2023. The clinical findings to date using lifespin’s technology platform in a research-use-only context are highly promising. Connect with Dr Ali. https://lifespin.health <a href="https://www.linkedin.com/in/dralitinazli/" rel="nofollow" target="_blank">https://www.linkedin.com/in/dralitinazli/</a> Keep in touch with Lifespin &amp; Dr Ali at industry events https://lifespin.health/newsroom/

Episode 6 - Dr Ali Tinazli - CEO - Lifespin

Orange County-based medical diagnostic company Fluxergy has taken the next step toward getting a high-speed test for COVID-19 available for use.  Fluxergy submitted an emergency use authorization request to the U.S. Food and Drug Administration Center For Devices and Radiological Health, seeking an authorization that would permit medical professionals to begin using the company’s test system as a COVID-19 diagnostic at the point-of-care. Advanced rapid point-of-care tests for COVID-19 may have the potential to save significant time compared to standard lab tests that must be shipped to centralized laboratories for processing. Fluxergy’s on-site sample- to-answer test for COVID-19 requires a very small sample, typically a nasal swab, which is mixed with a reagent solution, loaded onto a card and inserted into the analyzer in a two-step procedure.         In this episode of DeviceAlliance’s Medtech Radio we with speak CCO of Fluxergy, Dr. Ali Tinazli.  He also serves as Business Partner &amp; Strategy Advisor  with Immunaccel, and is a Member of the Strategic Advisory Board of InnVentis Ltd.  Join us as we discuss Fluxergy's goal to make laboratory testing accessible everywhere, the challenges facing current labs, and how our current environment is acting as a catalyst for the next generation of medical device innovation.

Dr. Ali Tinazli: Quick Turn Diagnostics | Ep.25